NEW YORK (GenomeWeb) – Illumina and Chinese clinical testing firm KingMed Diagnostics have partnered to develop next-generation sequencing-based oncology and hereditary disease diagnostics for the Chinese market.

Under the agreement, the companies will codevelop an NGS system based on Illumina's MiniSeq technology and KingMed's library prep kits and analysis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.